Matches in SemOpenAlex for { <https://semopenalex.org/work/W3189492537> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3189492537 abstract "Background Clozapine is generally considered as the treatment of choice for patients with treatment-resistant schizophrenia (TRS). However, its superiority has recently been questioned because olanzapine has been suggested as non-inferior to clozapine in its effectiveness. Aims We aimed to investigate the current status of clozapine prescriptions to identify any disparity between clinical guidelines and real-world practices. Method In this study, we utilised the Health Insurance Review Agency database in the Republic of Korea to investigate the real-world effectiveness of clozapine for patients with TRS. We compared differences in patient variables before and after clozapine administration, and we also performed survival analyses for both psychiatric admissions and emergency room visits among patients who used clozapine or olanzapine. Results This study investigated an incident cohort of 64 442 patients, and 2338 patients have been prescribed clozapine. Of these, 998 patients had TRS. In survival analysis, clozapine showed a worse survival rate for psychiatric admissions than olanzapine (hazard ratio 0.615). We also identified that clinicians tended to try a number of antipsychotics, as recommended, before starting patients on clozapine. Conclusions In conclusion, we found that olanzapine led to higher survival rates for psychiatric admissions than clozapine. Thus, considering the risk of serious adverse effects, clozapine may be used conservatively. Considering several studies advocating superior efficacy of clozapine, further studies with extensive data are recommended." @default.
- W3189492537 created "2021-08-16" @default.
- W3189492537 creator A5018181856 @default.
- W3189492537 creator A5045697381 @default.
- W3189492537 creator A5045758244 @default.
- W3189492537 creator A5048114826 @default.
- W3189492537 creator A5085858773 @default.
- W3189492537 date "2021-08-03" @default.
- W3189492537 modified "2023-10-14" @default.
- W3189492537 title "Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study" @default.
- W3189492537 cites W119903107 @default.
- W3189492537 cites W1970688947 @default.
- W3189492537 cites W1999764016 @default.
- W3189492537 cites W2067892283 @default.
- W3189492537 cites W2074782150 @default.
- W3189492537 cites W2084250773 @default.
- W3189492537 cites W2085295082 @default.
- W3189492537 cites W2089602570 @default.
- W3189492537 cites W2092965321 @default.
- W3189492537 cites W2104981156 @default.
- W3189492537 cites W2108022657 @default.
- W3189492537 cites W2121163156 @default.
- W3189492537 cites W2133209451 @default.
- W3189492537 cites W2149805979 @default.
- W3189492537 cites W2155379038 @default.
- W3189492537 cites W2270975510 @default.
- W3189492537 cites W2604742992 @default.
- W3189492537 cites W2608194486 @default.
- W3189492537 cites W2623053349 @default.
- W3189492537 cites W2739710241 @default.
- W3189492537 cites W2763046479 @default.
- W3189492537 cites W2776169777 @default.
- W3189492537 cites W2887788245 @default.
- W3189492537 cites W2972213548 @default.
- W3189492537 cites W3031161857 @default.
- W3189492537 cites W4211075559 @default.
- W3189492537 doi "https://doi.org/10.1192/bjo.2021.964" @default.
- W3189492537 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8358972" @default.
- W3189492537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34342261" @default.
- W3189492537 hasPublicationYear "2021" @default.
- W3189492537 type Work @default.
- W3189492537 sameAs 3189492537 @default.
- W3189492537 citedByCount "0" @default.
- W3189492537 crossrefType "journal-article" @default.
- W3189492537 hasAuthorship W3189492537A5018181856 @default.
- W3189492537 hasAuthorship W3189492537A5045697381 @default.
- W3189492537 hasAuthorship W3189492537A5045758244 @default.
- W3189492537 hasAuthorship W3189492537A5048114826 @default.
- W3189492537 hasAuthorship W3189492537A5085858773 @default.
- W3189492537 hasBestOaLocation W31894925371 @default.
- W3189492537 hasConcept C118552586 @default.
- W3189492537 hasConcept C126322002 @default.
- W3189492537 hasConcept C207103383 @default.
- W3189492537 hasConcept C2776412080 @default.
- W3189492537 hasConcept C2776619155 @default.
- W3189492537 hasConcept C2780864610 @default.
- W3189492537 hasConcept C44249647 @default.
- W3189492537 hasConcept C71924100 @default.
- W3189492537 hasConceptScore W3189492537C118552586 @default.
- W3189492537 hasConceptScore W3189492537C126322002 @default.
- W3189492537 hasConceptScore W3189492537C207103383 @default.
- W3189492537 hasConceptScore W3189492537C2776412080 @default.
- W3189492537 hasConceptScore W3189492537C2776619155 @default.
- W3189492537 hasConceptScore W3189492537C2780864610 @default.
- W3189492537 hasConceptScore W3189492537C44249647 @default.
- W3189492537 hasConceptScore W3189492537C71924100 @default.
- W3189492537 hasIssue "5" @default.
- W3189492537 hasLocation W31894925371 @default.
- W3189492537 hasLocation W31894925372 @default.
- W3189492537 hasOpenAccess W3189492537 @default.
- W3189492537 hasPrimaryLocation W31894925371 @default.
- W3189492537 hasRelatedWork W1556261663 @default.
- W3189492537 hasRelatedWork W2024417877 @default.
- W3189492537 hasRelatedWork W2116255116 @default.
- W3189492537 hasRelatedWork W2339460882 @default.
- W3189492537 hasRelatedWork W2364560884 @default.
- W3189492537 hasRelatedWork W2367334487 @default.
- W3189492537 hasRelatedWork W2377247545 @default.
- W3189492537 hasRelatedWork W2386570245 @default.
- W3189492537 hasRelatedWork W2392237104 @default.
- W3189492537 hasRelatedWork W2884007892 @default.
- W3189492537 hasVolume "7" @default.
- W3189492537 isParatext "false" @default.
- W3189492537 isRetracted "false" @default.
- W3189492537 magId "3189492537" @default.
- W3189492537 workType "article" @default.